68Ga PSMA-11 in Patients With Intermediate to High-risk Prostate Cancer Before Prostatectomy or With Biochemical Recurrence of Prostate Cancer.
Latest Information Update: 15 Mar 2022
At a glance
- Drugs Gallium (68Ga) gozetotide (Primary)
- Indications Adenocarcinoma; Prostate cancer
- Focus Diagnostic use; Expanded access
Most Recent Events
- 11 Mar 2022 Status changed from recruiting to completed.
- 02 Jul 2020 New trial record